Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV.
Gupta A, Righi E, Konnova A, Sciammarella C, Spiteri G, Van Averbeke V, Berkell M, Hotterbeekx A, Sartor A, Mirandola M, Malhotra-Kumar S, Azzini AM, Pezzani D, Monaco MGL, Vanham G, Porru S, Tacconelli E, Kumar-Singh S.
Gupta A, et al. Among authors: monaco mgl.
J Med Virol. 2024 Aug;96(8):e29820. doi: 10.1002/jmv.29820.
J Med Virol. 2024.
PMID: 39056205